Cargando…
DeSigN: connecting gene expression with therapeutics for drug repurposing and development
BACKGROUND: The drug discovery and development pipeline is a long and arduous process that inevitably hampers rapid drug development. Therefore, strategies to improve the efficiency of drug development are urgently needed to enable effective drugs to enter the clinic. Precision medicine has demonstr...
Autores principales: | Lee, Bernard Kok Bang, Tiong, Kai Hung, Chang, Jit Kang, Liew, Chee Sun, Abdul Rahman, Zainal Ariff, Tan, Aik Choon, Khang, Tsung Fei, Cheong, Sok Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310278/ https://www.ncbi.nlm.nih.gov/pubmed/28198666 http://dx.doi.org/10.1186/s12864-016-3260-7 |
Ejemplares similares
-
Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2021) -
K-Map: connecting kinases with therapeutics for drug repurposing and development
por: Kim, Jihye, et al.
Publicado: (2013) -
Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
por: Zainal, Nur Syafinaz, et al.
Publicado: (2019) -
SigWinR; the SigWin-detector updated and ported to R
por: de Leeuw, Wim C, et al.
Publicado: (2009) -
Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies
por: Fadlullah, Muhammad Zaki Hidayatullah, et al.
Publicado: (2016)